News | June 29, 2023
Granules India and Central Bureau of Narcotics unite to tackle drug abuse
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
Specialty Chemicals grew 38% YoY for FY23
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Subscribe To Our Newsletter & Stay Updated
